Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
1.
Exp Eye Res ; 246: 110015, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39089568

RESUMO

Fragile X Syndrome (FXS), the most common inherited form of human intellectual disability, is a monogenic neurodevelopmental disorder caused by a loss-of-function mutation of the FMR1 gene. FMR1 is encoding the Fragile X Messenger Ribonucleo Protein (FMRP) an RNA-binding protein that regulates the translation of synaptic proteins. The absence of FMRP expression has many important consequences on synaptic plasticity and function, leading to the FXS clinical phenotype. Over the last decade, a visual neurosensorial phenotype had been described in the FXS patients as well as in the murine model (Fmr1-/ymice), characterized by retinal deficits associated to retinal perception alterations. However, although the transcriptomic profile in the absence of FMRP has been studied in the cerebral part of the central nervous system (CNS), there are no actual data for the retina which is an extension of the CNS. Herein, we investigate the transcriptomic profile of mRNA from whole retinas of Fmr1-/ymice. Interestingly, we found a specific signature of Fmrp absence on retinal mRNA expression with few common genes compared to other brain studies. Gene Ontology on these retinal specific genes demonstrated an enrichment in retinal development genes as well as in synaptic genes. These alterations could be linked to the reported retinal phenotype of the FXS condition. In conclusion, we describe for the first time, retinal-specific transcriptomic changes in the absence of FMRP.


Assuntos
Modelos Animais de Doenças , Proteína do X Frágil da Deficiência Intelectual , Síndrome do Cromossomo X Frágil , Retina , Transcriptoma , Proteína do X Frágil da Deficiência Intelectual/genética , Proteína do X Frágil da Deficiência Intelectual/metabolismo , Animais , Camundongos , Retina/metabolismo , Síndrome do Cromossomo X Frágil/genética , Síndrome do Cromossomo X Frágil/metabolismo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Camundongos Endogâmicos C57BL , Perfilação da Expressão Gênica , Camundongos Knockout , Regulação da Expressão Gênica/fisiologia , Masculino
5.
Exp Eye Res ; 245: 109964, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38851478

RESUMO

To prevent ocular pathologies, new generation of dietary supplements have been commercially available. They consist of nutritional supplement mixing components known to provide antioxidative properties, such as unsaturated fatty acid, resveratrol or flavonoids. However, to date, few data evaluating the impact of a mixture mainly composed of those components (Nutrof Total®) on the retina are available. Only one in-vivo preclinical study demonstrated that dietary supplementation (DS) prevents the retina from light-induced retinal degeneration; and only one in-vitro study on Müller cells culture showed that glutamate metabolism cycle was key in oxidative stress response. Therefore, we raised the question about the in-vivo effect of DS on glutamate metabolism in the retina. Herein, we showed that the dietary supplementation promotes in-vivo increase of retinal glutamine amount through a higher glutamine synthesis as observed in-vitro on Muller cells. Therefore, we can suggest that the promotion of glutamine synthesis is part of the protective effect of DS against retinal degeneration, acting as a preconditioning mechanism against retinal degeneration.


Assuntos
Antioxidantes , Suplementos Nutricionais , Ácidos Graxos Ômega-3 , Glutamina , Retina , Degeneração Retiniana , Glutamina/metabolismo , Animais , Antioxidantes/farmacologia , Ácidos Graxos Ômega-3/administração & dosagem , Degeneração Retiniana/metabolismo , Degeneração Retiniana/prevenção & controle , Retina/metabolismo , Retina/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Células Cultivadas , Células Ependimogliais/metabolismo , Células Ependimogliais/efeitos dos fármacos , Masculino , Ratos , Modelos Animais de Doenças
6.
HLA ; 103(4): e15470, 2024 04.
Artigo em Inglês | MEDLINE | ID: mdl-38566403

RESUMO

The new HLA-DPA1*01:182 allele differs from HLA-DPA1*01:03:01:04 by a single mismatch in exon 4.


Assuntos
Medula Óssea , Cadeias alfa de HLA-DP , Humanos , Alelos , Brasil , Teste de Histocompatibilidade
7.
HLA ; 103(2): e15407, 2024 02.
Artigo em Inglês | MEDLINE | ID: mdl-38372613

RESUMO

We identified two new HLA-DRB3 alleles in Brazilian individuals using next generation sequencing.


Assuntos
Medula Óssea , Humanos , Cadeias HLA-DRB3 , Alelos , Brasil
8.
HLA ; 103(1): e15343, 2024 01.
Artigo em Inglês | MEDLINE | ID: mdl-38193612

RESUMO

HLA-A*68:190:02 differs from A*68:190:01 by a single synonymous nucleotide change in exon 2.


Assuntos
Medula Óssea , Humanos , Alelos , Brasil , Éxons/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...